Preoperative embolization reduces blood loss and recurrence in aneurysmal bone cyst surgery: A retrospective cohort study

IF 1.2 4区医学 Q4 HEMATOLOGY

Transfusion and Apheresis Science Pub Date : 2025-08-20 DOI:10.1016/j.transci.2025.104240

İbrahim Kaya , İsmet Mert Erdoğan , Mustafa Çeltik , Yaman Karakoç , Muhammed Furkan Tosun , Özlem Orhan , Coşkun Ulucaköy

{"title":"Preoperative embolization reduces blood loss and recurrence in aneurysmal bone cyst surgery: A retrospective cohort study","authors":"İbrahim Kaya , İsmet Mert Erdoğan , Mustafa Çeltik , Yaman Karakoç , Muhammed Furkan Tosun , Özlem Orhan , Coşkun Ulucaköy","doi":"10.1016/j.transci.2025.104240","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>This study aims to evaluate the effectiveness of preoperative embolization in reducing intraoperative blood loss and transfusion requirements, as well as its impact on recurrence in patients with histopathologically confirmed aneurysmal bone cysts (ABCs).</div></div><div><h3>Methods</h3><div>A retrospective review was conducted on 107 patients who underwent surgical treatment for ABC at a tertiary oncology center between 2004 and 2023. Patients were grouped based on whether they received preoperative embolization (n = 50) or not (n = 57). Data collected included demographic features, lesion location, estimated blood loss (EBL), erythrocyte suspension (ES) transfusion volume, operative time, VAS scores, and recurrence rates.</div></div><div><h3>Results</h3><div>Patients in the embolization group had significantly lower EBL (772 ± 445.4 ml vs. 1220.17 ± 523.37 ml; p < 0.001), VAS scores (2.14 ± 1.92 vs. 3.61 ± 2.52; p = 0.002), and ES transfusion volumes (312 ± 337.2 ml vs. 580.7 ± 394.8 ml; p < 0.001). Recurrence rates were also lower in the embolization group (8 % vs. 24.6 %; p = 0.023). Operative time did not differ significantly (p = 0.089).</div></div><div><h3>Conclusion</h3><div>In conclusion, the use of preoperative embolization in patients with aneurysmal bone cysts may help reduce intraoperative blood loss, transfusion requirements, and the likelihood of postoperative recurrence. In light of its potential to minimize both intraoperative complications and long-term recurrence, embolization should be considered as a component of preoperative planning in appropriately selected cases of ABC.</div></div>","PeriodicalId":49422,"journal":{"name":"Transfusion and Apheresis Science","volume":"64 6","pages":"Article 104240"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion and Apheresis Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1473050225001788","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

This study aims to evaluate the effectiveness of preoperative embolization in reducing intraoperative blood loss and transfusion requirements, as well as its impact on recurrence in patients with histopathologically confirmed aneurysmal bone cysts (ABCs).

Methods

A retrospective review was conducted on 107 patients who underwent surgical treatment for ABC at a tertiary oncology center between 2004 and 2023. Patients were grouped based on whether they received preoperative embolization (n = 50) or not (n = 57). Data collected included demographic features, lesion location, estimated blood loss (EBL), erythrocyte suspension (ES) transfusion volume, operative time, VAS scores, and recurrence rates.

Results

Patients in the embolization group had significantly lower EBL (772 ± 445.4 ml vs. 1220.17 ± 523.37 ml; p < 0.001), VAS scores (2.14 ± 1.92 vs. 3.61 ± 2.52; p = 0.002), and ES transfusion volumes (312 ± 337.2 ml vs. 580.7 ± 394.8 ml; p < 0.001). Recurrence rates were also lower in the embolization group (8 % vs. 24.6 %; p = 0.023). Operative time did not differ significantly (p = 0.089).

Conclusion

In conclusion, the use of preoperative embolization in patients with aneurysmal bone cysts may help reduce intraoperative blood loss, transfusion requirements, and the likelihood of postoperative recurrence. In light of its potential to minimize both intraoperative complications and long-term recurrence, embolization should be considered as a component of preoperative planning in appropriately selected cases of ABC.

查看原文本刊更多论文

术前栓塞可减少动脉瘤性骨囊肿手术的失血和复发：一项回顾性队列研究

目的本研究旨在评估术前栓塞在减少术中出血量和输血需求方面的有效性，以及对经组织病理学证实的动脉瘤性骨囊肿（ABCs）患者复发的影响。方法回顾性分析2004年至2023年在某三级肿瘤中心接受ABC手术治疗的107例患者。根据术前是否进行栓塞（n = 50）（n = 57）对患者进行分组。收集的数据包括人口统计学特征、病变部位、估计失血量（EBL）、红细胞悬液（ES）输血量、手术时间、VAS评分和复发率。ResultsPatients栓塞组有显著降低电子(772 ±445.4  1220.17毫升与 ±523.37  毫升;p & lt; 0.001),脉管得分(2.14 ±1.92 vs 3.61  ± 2.52;p = 0.002),和ES输血卷(312年 ±337.2  580.7毫升与 ±394.8  毫升;p & lt; 0.001)。栓塞组复发率也较低（8 % vs. 24.6 %;p = 0.023）。两组手术时间差异无统计学意义（p = 0.089）。结论术前栓塞治疗动脉瘤性骨囊肿有助于减少术中出血量、输血量和术后复发的可能性。鉴于栓塞术有可能减少术中并发症和长期复发，在适当选择的ABC病例中，栓塞术应被视为术前计划的一部分。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Transfusion and Apheresis Science 医学-血液学

CiteScore

3.60

自引率

5.30%

发文量

181

审稿时长

42 days

期刊介绍： Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues. Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators'' viewpoint. Another section is "What''s Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.